NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies

被引:139
|
作者
McDonagh, TA
Holmer, S
Raymond, I
Luchner, A
Hildebrant, P
Dargie, HJ
机构
[1] Univ Glasgow, Royal Infirm, Dept Cardiol, Glasgow G31 2ER, Lanark, Scotland
[2] Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G31 2ER, Lanark, Scotland
[3] Univ Copenhagen, Friedrichsberg Hosp, Copenhagen, Denmark
关键词
epidemiological studies; heart failure; cardio-renal distress;
D O I
10.1016/j.ejheart.2004.01.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Many studies have shown that the B-type natriuretic peptides (BNP and NT-proBNP) are proven diagnostic markers for heart failure due to left ventricular systolic dysfunction. The manner in which they are to be used is still being unravelled; most single centre studies have chosen the best concentration of the peptide on ROC analysis as their cut-point resulting in numerous different values for both BNP and NT-proBNP appearing in the literature. We report a different approach of defining an age and sex corrected abnormal concentration for NT-proBNP, derived from normal individuals within a large sample of 3051 subjects pooled from three European epidemiology studies and applying that to the entire population to detect HF and LVD. Three thousand and fifty one subjects were studied. Of these 10% (305) had significant LVD and 3.1% (94) had HE The median concentrations of NT-proBNP (IQR) in normals, those with LVD and in heart failure subjects were 20 pg/ml (10.30), 117.3 pg/ml (28.145) and 269.6 pg/ml (54.323), P<0.001, respectively. The area under the ROC curve for NT-proBNP for the detection of 'heart failure' was 0.85 and 0.69 for LVD. NT-proBNP was an independent predictor of the presence of HF on multivariate analysis. An abnormal NT-proBNP was defined as being > 95th centile for normals, age and sex corrected, and diagnosed HF with a sensitivity of 75% and a negative predictive value of 99%. In an additional analysis in a breathless subgroup of our population, in 30% a raised NT-proBNP concentration could be explained by HF due to LVD, in another 64% the high BNP level was associated with some other structural of functional cardiac abnormality or renal impairment. We were unable to assign a possible cause to the high NT-proBNP values in 5.9% of this breathless subgroup of the population. An abnormal NT-proBNP concentration is an accurate diagnostic test both for the exclusion of HF in the population and in ruling out LVD in breathless subjects. An elevated NT-proBNP merely indicates the presence of 'cardio-renal distress' and should prompt referral for further investigation. (C) 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:269 / 273
页数:5
相关论文
共 50 条
  • [41] The Role of NT-proBNP Levels in the Diagnosis of Hypertensive Heart Disease
    Mouzarou, Angeliki
    Hadjigeorgiou, Nikoleta
    Melanarkiti, Despo
    Plakomyti, Theodora Eleni
    DIAGNOSTICS, 2025, 15 (01)
  • [42] Measurement of NT-proBNP with LOCI® technology in heart failure patients
    Gruson, D.
    Ahn, Sylvie A.
    Lepoutre, Thibault
    Rousseau, Michel F.
    CLINICAL BIOCHEMISTRY, 2012, 45 (1-2) : 171 - 174
  • [43] The relationship between NT-proBNP and Depression in Patients with Heart Failure
    YingHui GAO
    Lin LIU
    Yu WANG
    Chao LIU
    Journal of Geriatric Cardiology, 2017, 14 (11) : 715 - 716
  • [44] The diagnostic value of serum and urinary NT-proBNP for heart failure
    Michielsen, Etienne C. H. J.
    Bakker, Jaap A.
    Van Kimmenade, Roland R. J.
    Pinto, Yigal M.
    Van Dieijen-Visser, Marja P.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2008, 45 : 389 - 394
  • [45] The mortality prediction of NT-proBNP in elderly patients with heart failure
    Kurt, O.
    Balta, S.
    Cakar, M.
    Unlu, M.
    Arslan, E.
    Demirkol, S.
    EUROPEAN GERIATRIC MEDICINE, 2013, 4 (02) : 121 - 121
  • [46] Serial NT-PROBNP determinations for the management of chronic heart failure
    De Bernardi, Alberto
    Spinnler, Maria Teresa
    JOURNAL OF CARDIAC FAILURE, 2006, 12 (06) : S31 - S31
  • [47] Evaluation of NT-proBNP to predict outcomes in advanced heart failure
    MacGowan, G. A.
    Neely, D.
    Peaston, R.
    Wrightson, N.
    Parry, G.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (07) : 892 - 899
  • [48] Variability of NT-ProBNP levels in patients with stable heart failure
    Araujo, J. P.
    Azevedo, A.
    Lourenco, P.
    Ferreira, A.
    Goncalves, F. Rocha
    Bettencourt, P.
    EUROPEAN HEART JOURNAL, 2006, 27 : 208 - 209
  • [49] NT-proBNP Response to Heart Failure Therapies An Imperfect Surrogate
    Cunningham, Jonathan W.
    Myhre, Peder L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (13) : 1333 - 1336
  • [50] Diagnostic value of NT-proBNP in children with chronic heart failure
    Arkhipova, E.
    Zharova, O.
    Basargina, E.
    Mayanskiy, N.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S132 - S132